title: Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemia.
authors: Hematology Department, Institut Paoli Calmettes, Marseille prebett@ipc.unicancer.fr.
authors: Thomas
authors: T
authors: Prebet
authors: Hematology Department, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse cedex 9.
authors: Sarah
authors: S
authors: Bertoli
authors: Hematology Department, Centre Hospital-Universitaire, Nantes.
authors: Jacques
authors: J
authors: Delaunay
authors: Hematology Department, Centre Hospitalier du Haut-Leveque, Pessac.
authors: Arnaud
authors: A
authors: Pigneux
authors: Laboratoire de Génétique, Centre Hospitalier Purpan, Toulouse.
authors: Eric
authors: E
authors: Delabesse
authors: Laboratoire de Biopathologie, Institut Paoli Calmettes, Marseille.
authors: Marie Joelle
authors: MJ
authors: Mozziconacci
authors: Laboratoire d' Hématologie Biologique, Centre Hospitalier du Haut-Leveque, Pessac.
authors: Audrey
authors: A
authors: Bidet
authors: Hematology Department, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse cedex 9 Laboratoire d' Hématologie, Institut Universitaire du Cancer de Toulouse Oncopole, France.
authors: Christian
authors: C
authors: Recher
authors: Hematology Department, Institut Paoli Calmettes, Marseille Université Aix-Marseille, Marseille, France.
authors: Norbert
authors: N
authors: Vey
mesh_terms: D018943:Anthracyclines / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D050660:Core Binding Factors / Q000235:genetics; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D018943:Anthracyclines; D000970:Antineoplastic Agents; D050660:Core Binding Factors
keywords: AML; CBF; daunorubicin intensification